Equol y daidzeina disminuyen la migración, invasión y la expresión génica de metaloproteinasa de la matriz (MMPs) en las líneas celulares prostáticas cancerosas DU-145 y PC-3 by Leiva, Bárbara et al.
  
© 2015  
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas 14 (3): 251 - 262 
ISSN 0717 7917 
www.blacpma.usach.cl 
 
 
Artículo Original | Original Article 
251 
 
Equol and daidzein decrease migration, invasion and matrix 
metalloproteinase (MMPs) gene expression in prostate cancer cell lines, 
DU-145 and PC-3 
[Equol y daidzeina disminuyen la migración, invasión y la expresión génica de metaloproteinasa de la matriz  
(MMPs) en las líneas celulares prostáticas cancerosas DU-145 y PC-3] 
 
Bárbara Leiva
1
, Ivo Carrasco
1
, Iván Montenegro
2
, Leonardo Gaete
3
, Igor Lemus
4
,  
Andrei Tchernitchin
3
, Rodrigo Bustamante
3
, Mario Párraga
1
 & Joan Villena
1
 
 
1Centro de Investigaciones Biomedicas, Universidad de Valparaíso, Chile 
2Escuela de Obstetricia y Puericultura, Facultad de Medicina, Universidad de Valparaíso, Chile  
3University of Chile Medical School, Laboratory of Experimental Endocrinology and Environmental Pathology LEEPA, ICBM 
4University of Chile School of Chemical & Pharmaceutical Sciences, Department of Pharmacological and Toxicological 
Chemistry.Contactos | Contacts: Mario Párraga - E-mail address: mario.parraga@uv.cl 
Chemistry.Contactos | Contacts: Joan Villena - E-mail address: juan.villena@uv.cl 
 
Abstract: This search is focused on the study of diet compounds that may have any potential chemopreventive effect against cancer. Some 
compounds that fulfill this requirement are phytoestrogens. Among them we find genistein (1), the most studied, daidzein (2) and equol (3) 
(figure 1). To compare the sensitivities of different prostate cancer cells to phytoestrogen treatment, sulphorhodamine B dye assay was 
performed to determine cell viability. DU-145 and PC-3 prostate cancer cell lines treated with various doses of phytoestrogen (0-12.5-25-50 
and 100 μM) for different times (24, 48 and 72h). For cell invasion or migration assay cells were seeded in a Transwell chamber with or 
without coating Matrigel respectively. DU-145 and PC-3 cells were treated previously with phytoestrogen (50 μM) for 24h. The study 
showed that equol, daidzein and genistein inhibited migration and invasion in prostate cancer cell lines. Moreover, we analyzed the effects 
of phytoestrogens in MMP-2 and MMP-9 mRNA expression by RT-PCR. The results indicated that equol, daidzein and genistein 
diminished the expression of MMP-2 and MMP-9 in a cell-dependent manner. Our data suggested that equol, daidzein and genistein 
inhibited migration and invasion in prostate cancer cell lines. Moreover, the results also suggest that down-regulation of MMP-2 and MMP-
9 might be involved in the inhibition of invasion of PC-3 and DU-145 cells after genistein, daidzein and equol treatment. 
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Resumen: Este trabajo se centra en el estudio de los compuestos de dieta que pueden tener potencial efecto quimiopreventivo contra el 
cáncer. Algunos de estos compuestos son los fitoestrógenos. Entre ellos encontramos la genisteína (1), el más estudiado, la daidzeína (2) y el 
equol (3) (figura 1). Para comparar el efecto de estos fitoestrogenos sobre las líneas celulares de cáncer de próstata, DU-145 y PC-3, se 
utilizó el ensayo de sulforodamina B para determinar la viabilidad celular tras los tratamientos con diferentes concentraciones de 
fitoestrógenos (0-12.5-25-50-100 µM) durante diferentes tiempos (24, 48, 72 h). Para analizar el efecto sobre la migración celular, las  
células DU-145 y PC-3 fueron tratadas previamente con una concentración de fitoestrógrno (50 µM) durante 24 horas y sembradas en una 
cámara Transwell sin recubrir. El estudio mostró que el equol, daidzeína y genisteína inhibió en MMP-2 y MMP-9 expresiones de genes en 
líneas celulares de cáncer de próstata, la PC-3 y DU-145. Los resultados indicaron que la daidzeína disminuyó la expresión de MMP- 2 y 
MMP-9 en DU-145 células. Nuestros datos sugieren que equol, daidzeína y genisteína inhiben la migración y la invasión de líneas celulares 
de cáncer de próstata. 
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INTRODUCTION 
Prostate cancer is one of the most commonly 
diagnosed cancers and the second leading cause of 
death in men in Western countries (Jemal et al., 
2008). Tumor metastasis is one of the major causes 
of morbidity in cancer patients (Partin et al., 2001). 
Unfortunately, no therapy has been developed that 
successfully targets metastasis-associated processes 
of any human cancer type (Overall & Lopez-Otin, 
2002). Cancer metastasis is a multistep process (Bajaj 
et al., 2005) including detachment, invasion, 
angiogenesis, adhesion to endothelial cells, 
extravasation and regrowth in distant organs. 
Invasion consists of three major processes: adhesion 
to the extracellular matrix (ECM), degradation of 
ECM by different kinds of proteolytic enzymes and 
migration (Bellon et al., 2004; Minard et al., 2004). 
Many studies have demonstrated that inhibition of the 
migration and the degradation of the ECM results in 
the prevention of metastasis (Hwang & 2006; Slivova 
et al., 2005; Valachovicova et al., 2004). Elevated 
extracellular protease activity increases the invasive 
activity of many cancer cell types, including prostate 
cancer cells (Stetler-Stevenson & Yu, 2001). 
The activation of MMP-2 and MMP-9 (also known 
as type IV collagenases or gelatinases) enables the 
degradation of the extracellular matrix (ECM) by 
tumor cells, allowing tumor metastasis (Itoh & 
Nagase, 2002).  
Both epidemiological and experimental 
evidence suggest that increased consumption of soy 
and soybased foods is associated with a decreased 
risk for prostate cancer (Hsing et al., 2000; Kolonel 
et al., 2000; Lee et al., 2003; Akata et al., 2004). Soy 
isoflavones are thought to be responsible, in part, for 
this observed protective effect. Soy contains two 
principal isoflavones, genistein and daidzein (Coward 
et al., 1993), that can modulate a variety of biological 
processes associated with carcinogenesis. Genistein 
and daidzein have been extensively studied. Their 
anticancer effects mainly included inhibition of cell 
proliferation, induction of cell cycle arrest and 
induction of apoptosis (Chen & Donovan, 2004; 
Hedlund et al., 2002; Hsu et al., 2009; Li et al., 2004; 
Li & Sarkar, 2002a; Li & Sarkar 2002b; Shen et al., 
2000; Shenouda et al., 2004). Equol is an active 
metabolite formed by intestinal bacteria from 
daidzein. Several independent lines of evidence 
suggest that equol may be one of the most 
biologically active metabolites (Lampe, 2010). Equol 
have significantly longer half-live in the body than 
daidzein or genistein (Kelly et al., 1995). Equol is 
more potent than daidzein and genistein in terms of 
its antioxidant properties (Arora et al., 1998) and 
antiproliferative effects (Lund et al., 2004) in various 
cell types. Interesting observations have been made 
suggesting that equol may also have a protective role 
in the prostate. 
The expression of various metalloproteinases 
(MMPs) in human prostate cancer cells was inhibited 
by genistein treatment (Li et al., 2004; Wang et al., 
2004), while there are a few studies on the migration 
and invasion effects of daidzein and equol previously 
in prostate cancer cells (Magee et al., 2006; Zheng et 
al., 2012]. A recent study provides the only evidence 
to date that equol has direct effects on the growth of 
human prostate cancer cells (Lampe, 2010; Lund et 
al., 2004; Magee et al., 2006; Mitchell et al., 2000; 
Zheng et al., 2012). In these studies there are 
controversie between used concentrations ranging 
from 10
-5
 to 10
-4
 M. 
The current study was therefore undertaken 
to elucidate the effect of equol and daidzein 
phytoestrogen compounds in prostate cancer cell 
migration and invasion, for which there are few 
avalaible data. Furthermore, we evaluated the effects 
of these compounds on the expression of two matrix 
metalloproteinase genes (MMP-2 and MMP-9). 
 
MATERIAL AND METHODS 
Cell culture and phytoestrogens treatment 
Human androgen-independent prostate cancer cells 
PC-3 and DU-145 were cultured in DMEM (Gibco, 
San Diego, CA, USA) supplemented with 10% (v/v) 
fetal bovine serum (FBS) at 37° C in a humidified 
5% CO2 incubator. 
For phytoestrogen treatment, appropriate 
volumes of stock solution (1 mM in ethanol) of 
phytoestrogen (Sigma, St Louis, MO, USA) were 
added to the medium to achieve the indicated 
concentrations (12.5, 25, 50, and 100 μM) and were 
then incubated with cells for the indicated periods of 
time (24, 48 and 72 hours). Stock solution of 
compounds was prepared in ethanol and the final 
concentration of this solvent was kept constant at 
0.1%. Control cultures received 1% ethanol alone. 
 
Cell viability by sulphorhodamine dye assay 
To compare the sensitivities of different prostate 
cancer cells to phytoestrogen treatment, 
sulphorhodamine B (SRB) (Sigma, St Louis, MO, 
USA) dye assay was performed to determine cell 
viability. DU-145 and PC-3 prostate cancer cell lines 
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were seeded at the density of 3×10
3
 cells/well in 96-
well plates for 24 h and then treated with various 
doses of phytoestrogen (0-12.5-25-50 and 100 μM) 
for different times (24, 48, 72 h). After the exposure 
time, in vitro cytotoxicity was measured by the SRB 
dye assay. Cells were fixed by adding 25 µL of cold 
50% (wt/vol) trichloroacetic acid (TCA) and 
incubated for 60 min at 4º C. Plates were washed 
with deionized water and dried; 50 µL of SRB 
solution (0.1% wt/vol in 1% acetic acid) were added 
to each microtiter well and incubated for 30 min at 
room temperature. Unbound SRB was removed by 
washing with 1% acetic acid. Plates were air-dried 
and bound stain was solubilized with 100 µL of Tris 
base (10 mM). Optical densities were read on an 
automated spectrophotometer plate reader at a single 
wavelength of 540 nm. Values are shown as the % 
viability vs. ctrl +/- SD, n = four independent 
experiments in triplicate. 
 
Wound healing assay 
To determine the effect of phytoestrogens on 
migration of DU-145 and PC-3 cells in vitro, cells 
were seeded at a density of 2×10
5
 cells in 24 well 
plates and grew to about 90 - 95% confluence after 
48 h. Medium was removed and cell monolayers 
were wounded by manually scraping cell layer with a 
1 ml plastic pipette tip. Debris was removed from the 
culture by washing with PBS twice, and cells were 
then cultured with fresh medium containing 
phytoestrogen (50 μM) for 24 h. Images were 
captured immediately after wounding and 24 h later. 
Wound closure was monitored with a Olympus® IX 
81 model inverted microscope. Wound sizes were 
measured with a scale to ensure that all wounds had 
initially the same width. 
The wound area was measured with ImageJ 
software at time = 0 and time = 24 h After that the 
following formula was applied:  
 
% Wound Area t24 = (Wound Area (t0) – Wound Area (t24)/Wound Area (t0))x 100 
 
Cell migration and invasion assays 
For cell migration assay cells were seeded in a 
Transwell chamber without coating Matrigel. DU-
145 and PC-3 cells were treated previously with 
phytoestrogen (50 μM) for 24h. Treated cells were 
then seeded into the upper chamber with 2×10
5
 
cells/well in 300 μL of serum-free medium, and 0.5 
ml medium containing 20% FBS was added to the 
lower chamber as a chemoattractant. After incubation 
for 24 h at 37° C in 5% CO2, the upper surface of the 
porous membrane was wiped off with a cotton swab. 
Cells that migrated to the lower surface of the porous 
membrane were fixed with 50% methanol and stained 
with 0.1% Crystal Violet.  
Cell invasion assay was conducted similarly 
in a Transwell chamber with coating Matrigel for 
48h. Matrigel (Sigma, Santiago, Chile) was diluted 
with serum-free medium to a final concentration of 2 
mg/mL, and 8 μm diameter pore polycarbonate 
membrane filters were coated with 50 μL of Matrigel. 
In both migration and invasion assays cell numbers 
were counted in twenty random fields (×100) per 
filter, in a total of three filter (n = 3). 
 
 
% Migration = (number of treated cells/number of control cells) x 100 
% Invasion = (number treated cells/number of control cells) x 100 
 
Quantitative Reverse transcription-polymerase 
chain reaction (qRT-PCR) 
After phytoestrogen treatment, total RNA was 
isolated from DU-145 and PC-3 cells using Trizol 
reagent (Invitrogen, Carlsbad, CA, USA) and 
quantitated by absorbance at 260 nm. RNA (2 μg) 
was reverse transcribed using MMLV reverse 
transcriptase according to the manufacturer’s 
instructions. MMP-2,-9 and GADPH mRNA 
expressions were determined by quantitative real-
time PCR which was conducted in a Light Cycler 
machine (Roche,) with capillary tubes. Briefly, each 
amplification mixture (20 μL) contains: 
 
 
2 ul of cDNA, 
10 ul of FAST EVAGreen qPCR Master Mix 
0,5 ul forward primer (F) 10 uM 
0,5 ul reverse primer (R) 10 uM 
2 ul BSA 0,1 mg/ml 
5 ul ultra pure water 
 
Cycling conditions were as follows: 96° C, 2 
min, 30 cycles of 96° C, 5 s; 58° C, 30 s; 72° C, 25 s. 
Reactions were finished with 72° C, 25s extension. 
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Primers used for MMP-2, MMP-9 and GAPDH: 
 
MMP-2 
(133 bp): 5’-CCTCCCTGCCCCTCCCTTCA-3’ (forward) 
and 5’-GCTTCTGGCTGGGTCTGTGGC-3’ (reverse); 
 
MMP-9 
(174 bp): 5’-GCCTTTGGACACGCACGACG-3’ (forward) 
and 5’-GCCAAAGCAGGACGGGAGCC-3’ (reverse); 
 
GAPDH 
(226 bp): 5’- GAAGGTGAAGGTCGGAGTC-3’ (forward) 
and 5’-GAAGATGGTGATGGGATTTC-3’ (reverse). 
 
After cycling conditions, a fusion curve was 
programmed so as to determine the Tm of the PCR 
product. This ensures the specificity of the amplified 
product.  
 
Statistical analysis 
All assays were repeated in triplicate in three 
independent experiments, and all data were expressed 
as means ± SEM. Analysis of variance (ANOVA) for 
multiple comparisons was used as noted. In all cases, 
P < 0.05 was considered significant. All statistical 
tests were performed with statistical analysis 
software. 
 
RESULTS AND DISCUSSION 
We exposed two human prostate cancer cell lines 
(PC-3, DU-145) to increasing concentrations of 
equol, daidzein or genistein and at different periods 
of time. Their effect on growth inhibition was 
compared using sulphorhodamine B dye assay (Table 
1). These cells displayed marked homogeneity in 
their responsiveness. As shown Table 1, daidzein and 
equol significantly inhibited cell viability in a dose- 
and time-dependent manner. Consistent with 
previous data, genistein significantly inhibited cell 
proliferation of PC-3 and DU-145 cells in a dose- and 
time-dependent manner. In dose-dependent 
experiments (72 h), the higher dosis of equol, 
daidzein and genistein (50-100 μM) was enough as to 
significantly decrease cell viability of PC-3 and DU-
145 cells. Lower concentrations of equol, daidzein 
and genistein (12.5-25 μM) not showed a significant 
growth inhibition of PC-3 and DU-145. Similarly, in 
time-dependent experiments, at the concentration 
analyzed (50 μM) of genistein, daidzein and equol 
the treatment was not enough to significantly 
decrease cell viability in PC-3 and DU-145 cells 
respectively at 24 h. At a concentration of 50 μM of 
genistein showed significant growth inhibition on 
PC-3 and DU-145 cells after 48h of treatment (p < 
0.05). Hence, treatments at a concentration of 50 μM 
for 24h were applied in the following experiments. 
These data indicated that equol, daidzein and 
genistein significantly inhibited growth of PC-3 and 
DU-145 in a dose- and time-dependent manner. 
 
Inhibitory effect on migration of PC-3 and DU-145 
cells by genistein, daidzein and equol 
The effect of phytoestrogens on migration was 
determined using a wound healing assay. As shown 
Figure 1 genistein, daidzein and equol inhibited 
migration in vitro for PC-3 and DU-145 cells. As 
shown Figure 1A the wounds in control healed better 
than the wounds treated with genistein, daidzein and 
equol (50 μM) in DU-145 cells. This inhibitory effect 
was similar for PC-3 cells (Figure 1B). In a 
quantitative analysis (Figure 1C), after 24 h treatment 
with either genistein, daidzein or equol, reduced the 
wound area by 68.1%, 57.1% and 62.0%, 
respectively in PC-3 cells. Similarly, the inhibition of 
migration after 24 h of treatment with genistein, 
daidzein or equol was 68.7%, 58.1% and 65.3% 
respectively in DU-145 cells. This inhibitory effect is 
significantly different (p < 0.001) in all treatments 
with respect to control cells in both PC-3 and DU-
145 cells. Our results indicate that used doses of 
phytoestrogens could lead to significant inhibition of 
wound healing (migration) of PC-3 and DU-145 
cells. 
The effect of phytoestrogens on migration 
was further analyzed using a Transwell chamber, as 
shown Figure 2A equol, daidzein and genistein could 
significantly reduce the migration of PC-3 (similar 
results are observed in DU-145 cells). A quantitative 
analysis, in the case of PC-3 cells (Figure 2B white 
columns) migrated cells after 50 μM equol, daidzein 
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or genistein treatment represent 54.8%, 65.1% or 
45.1% vs. control respectively. After genistein, 
daidzein and equol treatment (50 μM, 24 h), 49.4%, 
68.7% and 59.7% of migration (100%) were 
observed respectively in DU-145 (Figure 2B, black 
columns) versus control cells 
 
Table 1 
Effects of genistein, daidzein and equol on cell viability of prostate cancer cell lines, PC-3 and DU-145 
Cell viability (% of control) 
Cell line Treatment      
(µM) 
24 h 48 h 72 h 
PC-3 Equol         12.5   99.1 ± 7.5      97.4 ± 6.8      87.3 ± 7.9  
 Equol         25   92.3 ± 5.7      91.2 ± 7.1      79.0 ± 7.4 
 Equol         50   82.1 ± 9.1      78.1 ± 10.2      65.4 ± 6.3* 
 Equol       100   66.4 ± 5.2      61.6 ± 3.4      53.9 ± 4.4 
 Daidzein    12.5 100.3 ± 9.3      97.3 ± 7.8      84.2 ± 7.9 
 Daidzein    25   96.3 ± 5.1      94.7 ± 8.2      78.5 ± 6.9 
 Daidzein    50   80.9 ± 9.7      79.8 ± 8.3      72.1 ± 7.9* 
 Daidzein  100   70.8 ± 9.1      61.3 ± 6.6      58.5 ± 3.1 
 Genistein   12.5   98.1 ± 8.8      98.0 ± 7.4      83.1 ± 8.5 
 Genistein   25   94.1 ± 7.8      90.6 ± 7.9      76.7 ± 8.1 
 Genistein   50   81.2 ± 7.8      74.0 ± 5.8*      62.4 ± 7.4* 
 Genistein 100   60.8 ± 7.0      58.1 ± 6.2      51.7 ± 5.0 
 Equol         12.5   98.4 ± 8.6      98.1 ± 8.9      91.1 ± 10.3 
 Equol         25   96.3 ± 8.4      93.2 ± 6.8      81.4 ± 7.8 
DU-145 Equol         50   78.8 ± 6.6      76.5 ± 7.9      74.7 ± 6.1* 
 Equol       100   70.1 ± 8.1      68.2 ± 3.9      66.9 ± 4.8 
 Daidzein    12.5   99.3 ± 5.4      98.2 ± 8.6      93.5 ± 7.4 
 Daidzein    25   96.6 ± 9.8      90.1 ± 7.5      82.2 ± 8.9 
 Daidzein    50   84.7 ± 8.7      82.6 ± 7.8      78.3 ± 6.9* 
 Daidzein  100   78.2 ± 5.3      71.2 ± 5.9      68.9 ± 7.3 
 Genistein   12.5 100.3 ± 9.7    101.2 ± 9.2      93.4 ± 7.7 
 Genistein   25   87.4 ± 7.6      85.8 ± 9.3      82.1 ± 6.9 
 Genistein   50   78.3 ± 8.2      72.8 ± 6.7*      71.4 ± 7.8* 
 Genistein 100   75.1 ± 6.6      70.4 ± 8.1      67.6 ± 7.8 
After cells were treated with the indicated doses of phytoestrogen (0, 12.5, 25, 50 100 μM) at different times 
(24, 48, and 72h), cell viabilities were determined by sulphorhodamine B dye assay. Data shown are 
means±SD of four independent experiments. * p<0.05 vs. control 
 
Figure 1 
Isoflavones compounds. 
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Figure 2 
Inhibitory effects of phytoestrogens on the wound healing of PC-3 and DU-145 cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                       
Cells were treated with different phytoestrogens (genistein, daidzein, equol) (50 μM) for 24 h. (A) 
Representative photos of the wound healing inhibition of PC-3 after 50 μM genistein, daidzein 
and equol treatment (magnification×100). (B) Representative photos of the wound healing 
inhibition of PC-3 after 50 μM genistein, daidzein and equol treatment (magnification×100). (C) 
Quantification of the wound healing assay of DU-145 (black column) and PC-3 (open column). 
Data represent means±SEM of three independent experiments. * p < 0.001 vs. control. 
 
 
 
 
Insert wide diagram here. 
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Figure 3 
Inhibitory effects of phytoestrogens on the migration assay of PC-3 and DU-145 cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cells were treated with different phytoestrogens (genistein, daidzein, equol) (50 μM) for 24 h. (A) 
Representative photos of the wound healing inhibition of PC-3 after 50 μM genistein, daidzein and equol 
treatment (magnification×100). (B) Representative photos of the wound healing inhibition of PC-3 after 50 
μM genistein, daidzein and equol treatment (magnification×100). (C) Quantification of the wound healing 
assay of DU-145 (black column) and PC-3 (open column). Data represent means±SEM of three independent 
experiments. *p < 0.001 vs. control. 
 
Additionally, the effect of phytoestrogens on 
invasion was determined using a Transwell chamber 
coated with Matrigel. As is shown in Figure 3, 
genistein, daidzein and equol significantly reduced 
the invasion of DU-145 and PC-3 cells. In the case of 
PC-3 cells, equol, daidzein and genistein (50 μM) 
reduced significantly the invasion by 59.8%, 51.7% 
and 64.3% vs. control cells (p < 0.001). Treatment 
with equol, daidzein and genistein (50 μM, 48 h) 
diminished significantly (p < 0.001) the invasion of 
DU-145 by 60.5%, 51.2% and 63.4% respectively 
versus control cells. In both cell lines significant 
differences were observed between daidzein and 
equol and genistein treatments (p < 0.05).  
This inhibitory effect is significantly different 
(p < 0.001) in all treatments with respect to control 
cells in both DU-145 and PC-3 cells. Moreover, 
differences between treatments are shown 
specifically between daidzein treatment and genistein 
and equol treatments (p < 0.05). These results 
corroborate that equol, daidzein and genistein 
reduced significantly the migration of PC-3 and DU-
145 cells. 
To elucidate the possible underlying 
mechanisms of anti-invasive activities of genistein, 
daidzein and equol on PC-3 and DU-145 cells, we 
analyzed changes in MMP-2 and MMP-9 mRNA 
expression by RT-PCR. As shown in Table 2, 50 μM 
genistein treatment decreased MMP-2 and MMP-9 
mRNA by 61% and 57% respectively in DU-145 
cells. However, in PC-3 cells genistein had not effect 
on MMP-2 and reduced MMP-9 mRNA expression 
by 32%. Daidzein treatment also decreased MMP-2 
and MMP-9 mRNA by 53% and 37% respectively in 
DU-145 cells but had not effect on MMP-2 and -9 
mRNA in PC-3 cells. Finally, equol (50 μM) had not 
effect on MMP-2 and -9 mRNA in DU-145 cells in 
contrast to PC-3 cells where equol decreased 28% 
and 39% on MMP-2 and -9 mRNA respectively 
(Table 2). 
 
 
 
 
 
 
 
 
Insert diagram here. 
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Figure 4 
Inhibitory effects of phytoestrogens on the invasion assay of PC-3 and DU-145 cells. 
 
 
 
Cells were treated with different phytoestrogens (genistein, daidzein, equol) (50 μM) for 48 h and then 
harvested and seeded into the upper chamber coated with Matrigel. The number of cells that invaded into 
the lower chamber represented the invasion capability. Quantification of the invasion assay of DU-145 (black 
column) and PC-3 (open column). Data represent means±SD of three independent experiments. * p<0.001 vs. 
control; # p<0.05 vs. genistein and equol treatments. 
 
 
Table 2 
Effects of genistein, daidzein and equol (50 μM) on MMP-2 and MMP-9 gene expression in prostate cancer 
cell lines DU-145 and PC-3 
 
 
  MMP-2     MMP-9 
DU-145    
 Genistein 0.39 ± 0.12**          0.43 ± 0.14** 
 Daidzein 0.47 ± 0.13**           0.63 ± 0.16* 
 Equol            1.02 ± 0.15 
PC-3    
 Genistein 0.99 ± 0.16           0.68*± 0.10 
 Daidzein 1.09 ± 0.21           1.13 ± 0.18 
 Equol   0.72 ± 0.09*           0.61 ± 0.11* 
 
 
Numbers show up-regulation (>1) or down-regulation (<1) of each gene in each of the treatments. Values are 
already normalized against GAPDH expression, which was used as reference gene.Data represent means±SD 
of three independent experiments. 
 
Together, these findings suggest that down-
regulation of MMP-2 and MMP-9 might be involved 
in the inhibition of invasion of PC-3 and DU-145 
cells after genistein, daidzein and equol treatment. 
Prostate cancer is one of the most commonly 
diagnosed cancers in Western countries (Jemal et al., 
2008). Epidemiological evidence suggests that 
increased consumption of soy and soy-based foods is 
associated with a decreased risk for prostate cancer 
(Hsing et al., 2000; Kolonel et al., 2000; Lee et al., 
2003). Interest in the effects of soy isoflavones 
focused mainly on genistein. Previous studies have 
reported that genistein inhibited the growth in 
LNCaP, DU-145 and PC-3 prostatic cancer cells (Li 
& Sarkar, 2002; Ouchi et al., 2005; Shen et al., 2000; 
Shenouda et al., 2004). Daidzein also inhibited 
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proliferation in LNCaP, PC-3 and DU-145 (Cao et 
al., 2006; Li & Sarkar 2002). 
The current study extends these findings to 
include equol, a secondary metabolite of daidzein 
because very few studies have analyzed the direct 
actions of equol in the prostate. A recent study by 
Mitchell et al.. provides evidence to date that equol 
has direct effects on the growth of human prostate 
cancer cells (Mitchell et al., 2000; Lund et al., 2004; 
Lampe 2010). Another study indicates that equol 
reduced in a dose and time-dependent manner the 
viability of benign and malignant prostatic cells, PC-
3 and DU-145 (Hedlund et al., 2002; Magee et al., 
2006). Our data corroborate these findings showing 
similar effects for equol and genistein and a minor 
effect for daidzein on cell viability decrease. 
Moreover, we compared the effects of the 
three phytoestrogens in prostate cancer cells (DU-145 
and PC-3) migration, invasion and MMP-2 and -9 
expressions.  
One important characteristic of metastasis is 
the migratory and invasive ability of tumor cells. We 
used wound healing and Boyden chamber assay to 
quantify the effect of phytoestrogens, equol, daidzein 
and genistein on the migratory potential of PC-3 and 
DU-145 cells. The results demonstrated that equol, 
daidzein and genistein significantly diminished 
migration in both cell lines, PC-3 and DU-145, in 
wound healing and Boyden chamber assay. Daidzein 
in both cases has a minor effect compared to 
genistein and equol according to previous data (Ju et 
al., 2006; Kang et al., 2007). These results were 
consistent with previous studies. Other data indicates 
that these phytoestrogens reduced migration in breast 
cancer cell lines, MCF-7 and MDA-MB-231 (Magee 
et al., 2006) and in ovarian cancer cell line, BG-1 
Hsu et al., 2009). Little data are available about the 
effect of equol on cellular migration (Zheng et al., 
2012). 
Furthermore, we used Boyden chamber assay 
to quantify the effect of phytoestrogens on invasion 
of PC-3 and DU-145 cells. The compounds also 
showed similar effects in inhibiting the invasion of 
prostatic cells through Matrigel at the concentration 
used. Daidzein has a significant minor effect 
compared to genistein and equol. Little data are 
avalaible about the effect of equol and daidzein on 
cellular invasion in prostate cancer cells (Magee et 
al., 2006; Zheng et al., 2012). 
Many reports have addressed the importance 
of interactions between cells and ECM, which could 
enhance cell migration, invasion, proliferation, and 
ECM degradation. Metastasis has been found to be 
accompanied by various physiological alterations 
involved in the degradation of ECM, such as the 
overexpression of proteolytic enzyme activity, such 
as MMPs, as well as the migration and invasion of 
tumor cells (Bellon et al., 2004; Minard et al., 2004). 
The expression of both MMP-2 and MMP-9 has been 
shown to play a critical role in degrading the 
basement membrane in cancer invasion and 
migration (Attiga et al., 2000). Moreover, the 
overexpression of MMP-9 is related to tumor 
invasion and metastasis in gastric carcinoma (Sun et 
al., 2005). Li et al., reported that the expression of 
MMP-2 and -9 has significant prognostic value in 
node-negative patients for predicting relapse free 
survival (Li et al., 2004). Increased MMP-2 
expression has been associated with a higher Gleason 
score, a more advanced disease stage and decreased 
disease-free survival (Trudel et al., 2003). 
Our study indicates that equol, daidzein and 
genistein inhibited on MMP-2 and -9 gene 
expressions in prostate cancer cell lines, PC-3 and 
DU 145. As shown in Table 1, our results indicated 
that daidzein diminished the expression of MMP-2 
and MMP-9 in DU-145 cells. However daidzein 
treatment has no effect on these two genes expression 
in PC-3 cells. By the other hand, equol decreased 
expression of both, MMP-2 and MMP -9 mRNA, in 
PC-3 cells having no effects in DU-145 cells. Finally, 
genistein reduced significantly the expression of 
MMP-9 in both cell lines but only diminished 
expression of MMP-2 in DU-145 cell line. These data 
are not in agreement with recent data indicating that 
equol and genistein inhibited MMP-2 and -9 in DU-
145 cells (Zheng et al., 2012) and that genistein 
reduced MMP-2 levels in PC-3 cells (Kumi-Diaka et 
al., 2006). Previously, it has been found that 
genistein down-regulated the expression of MMP-9, 
MMP-2, uPAR and other genes related to 
angiogenesis and metastasis by gene expression 
profiling of genistein treated PC-3 prostate cancer 
cells and PC-3 bone tumor (Li & Sarkar, 2002) and 
these data was further reported by studies showing 
inhibition of MMP-9 expression in PC-3 cells in vitro 
(Li et al., 2004) and the inhibition of MMP-2 
activation and reduction of prostate cancer cell 
invasion by genistein (Huang et al., 2005; Xu & 
Bergan, 2006). Taken together our data suggested 
that equol, daidzein and genistein inhibited migration 
and invasion in prostate cancer cell lines. Moreover, 
these results suggested that the anti-invasive effect of 
equol, daidzein and genistein was related to the 
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inhibition of enzymatically degradative processes of 
tumor metastasis associated to MMP-2 and -9 in a 
cell-type manner. These data indicates that it is 
possible to target motility-associated processes with 
equol, daidzein and genistein.  
Nevertheless, the underlying molecular 
mechanism of action of MMP-2 and -9 remain 
unknown and further research is required. 
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